Learn how crucial these factors are for the patient management with Rheumatoid Arthritis (RA).

Early detection. Early treatment.


Traditional tests for Rheumatoid Arthritis detect the autoantibodies rheumatoid factor and anti-cyclic citrullinated peptide (CCP). But neither test identifies all patients with the disorder, especially in the early stages when intervention can prevent more serious disease later. This session will discuss the role of citrullination in RA, the evolution of anti-CCP assays, and the search for antibodies to individual citrullinated proteins which may be used to complement anti-CCP in the diagnosis and management of RA. The utility of antibody to the mutated version of citrullinated vimentin will be highlighted.

Data del webinar
27 giugno 2024
Ora del webinar
6:00 PM


Holger Bang, PhD
Senior Scientific Advisor, Sebia
Roberto Fiorillo
Global Product Manager Autoimmunity, Sebia

Hai domande su questo webinar?